Novo Nordisk has introduced Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce ...

Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

A glucagon pen is meant to be used in cases when hypoglycemia is not responsive to treatment or when a person has lost consciousness. Glucagon injection side effects tend to be mild and may ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 ...

Danish pharma major Novo Nordisk launched Wegovy, its FDA-approved weekly weight-loss injection, in India on Tuesday. Priced ...

Over the past year, an increasing number of patients and healthcare providers have been turning their attention to Trulicity ...

A pen-injector formulation of a glucagon analogue from Zealand Pharma – dasiglucagon – is also in development and could be ready for filing early next year, potentially adding a third product ...

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

That price is a steep discount from the $1,349 list price for a month’s supply of the drug, a product administered in single-use, pre-filled injection pens. The new lower cash price for Wegovy ...

Until recently, several glucagon-like peptide-1 (GLP-1) injections were in shortage. During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of ...